Teleflex Incorporated Announces Quarterly Dividend of $0.34 (NYSE:TFX)

Teleflex Incorporated (NYSE:TFX) announced a quarterly dividend on Thursday, August 1st, NASDAQ reports. Stockholders of record on Thursday, August 15th will be paid a dividend of 0.34 per share by the medical technology company on Monday, September 16th. This represents a $1.36 annualized dividend and a dividend yield of 0.58%. The ex-dividend date is Thursday, August 15th.

Teleflex has a dividend payout ratio of 9.0% meaning its dividend is sufficiently covered by earnings. Equities analysts expect Teleflex to earn $15.18 per share next year, which means the company should continue to be able to cover its $1.36 annual dividend with an expected future payout ratio of 9.0%.

Teleflex Trading Down 0.2 %

Shares of TFX stock opened at $235.51 on Friday. Teleflex has a 52-week low of $177.63 and a 52-week high of $257.85. The company has a 50-day simple moving average of $213.52 and a two-hundred day simple moving average of $221.54. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.41 and a current ratio of 2.51. The company has a market capitalization of $11.09 billion, a price-to-earnings ratio of 37.89, a PEG ratio of 2.14 and a beta of 1.13.

Teleflex (NYSE:TFX) last released its earnings results on Thursday, August 1st. The medical technology company reported $3.42 EPS for the quarter, topping analysts’ consensus estimates of $3.33 by $0.09. Teleflex had a return on equity of 14.78% and a net margin of 9.82%. The company had revenue of $749.70 million for the quarter, compared to analysts’ expectations of $762.98 million. During the same period in the previous year, the business posted $3.41 EPS. The business’s revenue for the quarter was up .9% compared to the same quarter last year. Research analysts anticipate that Teleflex will post 13.75 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities research analysts have commented on the stock. Needham & Company LLC reaffirmed a “hold” rating on shares of Teleflex in a report on Friday, May 3rd. Piper Sandler upgraded shares of Teleflex from a “neutral” rating to an “overweight” rating and lifted their price objective for the company from $205.00 to $245.00 in a research note on Monday, July 1st. Finally, Truist Financial increased their target price on Teleflex from $235.00 to $240.00 and gave the stock a “hold” rating in a research report on Tuesday, July 16th. Three equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $263.14.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.